Home  / Bills, meetings, and session  / Bills  / Bill summary  / SB 6127

Search for another bill

Search for another bill or initiative

SB 6127 - 2023-24

Increasing access to human immunodeficiency virus postexposure prophylaxis drugs or therapies.
Sponsors: Liias, Rivers, Muzzall, Randall, Frame, Hasegawa, Kuderer, Lovick, Nobles, Pedersen

Bill history

View all roll calls on this bill

2024 Regular Session

In the Senate

Jan 10
First reading, referred to Health & Long Term Care. (View original bill)
Jan 18
Public hearing in the Senate Committee on Health & Long Term Care at 10:30 AM. (Committee materials)
Jan 26
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass. (View 1st substitute) (Majority report)
Jan 29
Passed to Rules Committee for second reading.
Feb 6
Placed on second reading by Rules Committee.
Feb 7
1st substitute bill substituted (HLTC 24). (View 1st substitute)
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (View 1st engrossed) (View this roll call)

In the House

Feb 9
First reading, referred to Health Care & Wellness.
Feb 14
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee materials)
Feb 16
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 8:00 AM. (Committee materials)
Feb 20
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee materials)
HCW - Majority; do pass with amendment(s). (Majority report)
Feb 21
Referred to Rules 2 Review.
Feb 24
Rules Committee relieved of further consideration. Placed on second reading.
Feb 27
Committee amendment(s) adopted with no other amendments.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 95; nays, 0; absent, 0; excused, 3. (View this roll call)

In the Senate

Mar 5
Senate concurred in House amendments.
Passed final passage; yeas, 48; nays, 0; absent, 0; excused, 1. (View this roll call)
Mar 6
President signed.

In the House

Mar 7
Speaker signed.

Other than legislative action

Mar 8
Delivered to Governor. (View bill as passed legislature)
Mar 25
Governor signed.
Chapter 251, 2024 Laws. (View session law)
Effective date 1/1/2025.

Available documents

For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.

Fiscal note

Amendments

Available videos